HRSA Awards $89.3 Million for Rural Addiction Treatment and Recovery

The Health Resources and Services Administration announced on September 25, 2026, that it awarded $89.3 million through the Rural Communities Opioid Response Program to expand substance use disorder prevention, treatment and recovery services in rural communities across the country. The largest share — $62.7 million — goes to the RCORP-Impact tier, which funds integrated and coordinated treatment and recovery services. Another $12.6 million supports RCORP-Overdose Response, aimed at immediate overdose prevention needs, with the remainder directed to planning and technical assistance work.

Where the money lands

HRSA, the agency inside the Department of Health and Human Services that runs the program through its Federal Office of Rural Health Policy, said award recipients will strengthen evidence-based services, build the rural substance use disorder workforce, coordinate health and supportive services, and develop community networks meant to sustain recovery beyond the grant period. The awards follow a funding cycle that opened earlier this year with a July 8 application deadline and an advertised $60 million ceiling for up to 80 RCORP-Impact grants.

The structure reflects a decade of federal experience with rural opioid money. RCORP deliberately funds consortia rather than single clinics, requiring grantees to assemble hospitals, primary care practices, behavioral health providers, law enforcement, schools and recovery organizations into a shared service plan. The theory is that a county with 8,000 residents cannot sustain a standalone addiction program, but a network spanning four counties can.

Why rural access remains the harder problem

The new money arrives against a stubborn geography of care. CDC researchers reported in Morbidity and Mortality Weekly Report that the share of emergency departments administering buprenorphine for opioid use disorder rose from roughly 7 percent to 31 percent in urban counties between 2019 and 2025, but only from 2 percent to 10 percent in rural counties. Pharmacy stocking moved in the opposite direction: pharmacists in rural areas who stocked the medication rose from about 70 percent to 80 percent, outpacing the urban increase from 65 percent to 72 percent, and average prescription supply lengthened across both settings.

That divergence matters because medication for opioid use disorder works best when it starts immediately. Dr. Jeanmarie Perrone, founding director of Penn Medicine's Center for Addiction Medicine and Policy, told WHYY that rural emergency physicians may hesitate to write a prescription when they cannot see where a patient will follow up. "There's probably some concern about writing a prescription when they don't know where the patient is going to follow up," she said, pointing to the shortage of intensive outpatient programs and long-term clinics outside metro areas.

Perrone's team has turned to telehealth to bridge some of that distance, using remote coordination to keep patients connected to medication-assisted treatment when appointments lapse or a pharmacy runs short. She described the model as a safety net that could be extended across Pennsylvania and other states with large rural populations.

What grantees have to show

RCORP carries an evaluation burden unusual for rural grant programs. Recipients report on core activities and benchmarks, and HHS's Office of Inspector General audited the program's award recipients in 2025, finding that the group generally met required activities and proposed targets. The technical assistance arm is itself a funded cooperative agreement that provides hands-on support to grantees on data collection, workforce recruitment and sustainability planning, a recognition that small rural organizations often lack the administrative staff to manage federal reporting alone.

Workforce is the recurring constraint. Rural health systems have struggled for years to recruit and retain addiction counselors, psychiatric prescribers and nurses, and the funding language explicitly targets that gap rather than assuming clinical staff can be hired once the grant lands. Some of the money flows toward training and career pathway programs that pull local residents into behavioral health roles.

The bigger federal picture

The September awards arrive as the administration reshapes addiction policy on several fronts at once. HHS has canceled or restructured a series of programs over the past year, merged several agencies into a new Administration for a Healthy America, and shifted grant language away from harm reduction while sustaining medication-based treatment. In that environment, RCORP has survived largely intact — a rural-focused program with bipartisan support in Congress and a record that its overseers can point to.

Whether the $89.3 million changes outcomes in the counties it reaches will depend on what happens after the grant period ends. Past RCORP cohorts have cycled through planning grants that never converted to sustained funding, and some communities have built networks that dissolved when federal support lapsed. This round asks recipients to show that the services they build, particularly opioid use disorder treatment capacity and recovery supports, can outlast it.